FDA Approves Supplement for Risperidone by Heritage Pharma
The FDA has approved a supplement for the ANDA076228 application for Risperidone submitted by Heritage Pharma.
Company
Pharmaceutical intelligence for Heritage Pharma with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.